Informaは企業と専門家を数百の方法でサポートしています。

私たちの国際的なライブイベント、世界をリードする研究出版物、革新的なデジタルサービスのポートフォリオは、専門家が成功するために必要な知識と人脈を提供しています。

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Dr. Kumiko Ui-Tei, PhD
Institute of Science Tokyo における Director/Professor NucleoTIDE & PepTIDE Drug Discovery Center at Institute of Science Tokyo
スピーカー

プロフィール

Kumiko Ui-Tei is a Director and Professor at the NucleoTIDE and PepTIDE Drug Discovery Center, Institute of Biomedical Engineering, Institute of Science Tokyo. She also serves as a Project Researcher at the Graduate School of Science, the University of Tokyo, and a Visiting Professor at the Center for Nucleic Acid Drug Development, Tokyo University of Science. She is a Co-founder and a Chief Technology Officer (CTO) of ANRis Therapeutics, a biotech startup established in 2023 to advance the real-world implementation of SNPD-siRNA therapeutics. In 2019, she received the Academic Award of the Nucleic Acids Therapeutics Society of Japan in recognition of her outstanding contributions to the field.

アジェンダセッション

  • Precision-Engineered SNPD-siRNAs for Allele-Specific Silencing of Disease-Causing Mutations

    1:45pm